SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-300850
Filing Date
2014-08-07
Accepted
2014-08-07 16:46:16
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d756777d10q.htm 10-Q 342349
2 EX-31.1 d756777dex311.htm EX-31.1 8738
3 EX-31.2 d756777dex312.htm EX-31.2 8871
4 EX-32.1 d756777dex321.htm EX-32.1 4161
5 EX-32.2 d756777dex322.htm EX-32.2 4482
  Complete submission text file 0001193125-14-300850.txt   3163255

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aeri-20140630.xml EX-101.INS 431520
7 XBRL TAXONOMY EXTENSION SCHEMA aeri-20140630.xsd EX-101.SCH 35863
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aeri-20140630_cal.xml EX-101.CAL 50591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aeri-20140630_def.xml EX-101.DEF 81007
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeri-20140630_lab.xml EX-101.LAB 268614
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeri-20140630_pre.xml EX-101.PRE 178527
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36152 | Film No.: 141024514
SIC: 2836 Biological Products, (No Diagnostic Substances)